Ranbaxy Spokesman: Have Discontinued Drug Discovery Pact With Merck
January 06, 2011 at 00:04 AM EST
BANGALORE -(Dow Jones)- Ranbaxy Laboratories Ltd. (500359.BY) has discontinued a drug discovery and clinical development collaboration with Merck & Co. Inc. (MRK) aimed at developing new anti-bacterial and anti-fungal drugs, a spokesman for the Indian drug maker said Thursday.
